Kikuchi, Tetsuro,Maeda, Kenji,Guy, Geoffrey,Robson, Philip,Stott, Colin
申请号：
HUE13152600
公开号：
HUE047214T2
申请日:
2008.12.17
申请国别(地区):
HU
年份:
2020
代理人:
摘要：
The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD)； cannabidiolic acid (CBDA)； tetrahydrocannbidivarin (THCV)； tetrahydrocannbidivarinin acid (THCVA)； cannabichromene (CBC)； cannabichromenic acid (CBCA)； cannabigerol (CBG) and cannabigerolic acid (CBGA). Preferably the anti-psychotic medication is an atypical anti-psychotic medication.
